May
07

MycoDev Receives $500K in Venture Capital Investment

By

MycoDev Receives $500K in Venture Capital InvestmentNBIF today announced a $500,000 venture capital investment in MycoDev Group Inc. MycoDev’s main product, a biopolymer called chitosan, is highly sought after by a wide variety of industries, especially the pharmaceutical and medical device industries.

“Chitosan is an extremely effective coagulant that, when combined with other agents, can almost immediately stop bleeding and promote healing in humans,” says NBIF CEO Calvin Milbury, “although chitosan is already on the market, its traditional production method leaves impurities that can prevent its use in pharmaceutical products.”…

MycoDev Receives $500K in Venture Capital Investment

Share
Categories : Uncategorized

Leave a Reply

You must be logged in to post a comment.